PharVision Advisers’s Intapp INTA Stock Holding History

PharVision Advisers’s Portfolio INTA Stock Details INTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,025	Closed	-$259K	–	721
2025 Q2	$259K	Buy	+5,025	New	+$274K	0.37%	122

Other funds holding INTA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PIMC

Praesidium Investment Management Company New York $419M AUM 4.58% 1-Year Est. Return

PharVision Advisers's INTA Position: Q3 2025 in Review

PharVision Advisers sold out of Intapp (INTA) in Q3 2025, closing a stake of 5,025 shares — an estimated $259K sold.

PharVision Advisers first reported a position in INTA in Q2 2025 and held it in 1 quarter. The position peaked at $259K in Q2 2025. 261 funds tracked by Wall St. Rank hold INTA as of Q3 2025.

PharVision Advisers reported no remaining Intapp position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 5,025 Intapp shares in Q3 2025, an estimated $259K.
PharVision Advisers first reported a position in Intapp in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Intapp position peaked at $259K in Q2 2025.
261 funds tracked by Wall St. Rank held Intapp as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.